Literature DB >> 12685992

Schizotaxia: current status and future directions.

Ming T Tsuang1, William S Stone, Franziska Gamma, Stephen V Faraone.   

Abstract

Schizophrenia is a biologic disorder whose etiology involves a combination of genetic and environmental risk factors. In this review, the authors update the conceptual basis of schizotaxia, consider evidence for its validity, and look toward its likely evolution in the future.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12685992     DOI： 10.1007/s11920-003-0029-x

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN： 1523-3812            Impact factor:   5.285


  46 in total

1.  Family history of type 2 diabetes in schizophrenic patients.

Authors:  S Mukherjee; D B Schnur; R Reddy
Journal:  Lancet       Date:  1989-03-04       Impact factor: 79.321

2.  Thalamic and amygdala-hippocampal volume reductions in first-degree relatives of patients with schizophrenia: an MRI-based morphometric analysis.

Authors:  L J Seidman; S V Faraone; J M Goldstein; J M Goodman; W S Kremen; R Toomey; J Tourville; D Kennedy; N Makris; V S Caviness; M T Tsuang
Journal:  Biol Psychiatry       Date:  1999-10-01       Impact factor: 13.382

Review 3.  Heterogeneity of schizophrenia. Conceptual models and analytic strategies.

Authors:  M T Tsuang; M J Lyons; S V Faraone
Journal:  Br J Psychiatry       Date:  1990-01       Impact factor: 9.319

4.  Poor blood glucose regulation predicts sleep and memory deficits in normal aged rats.

Authors:  W S Stone; G L Wenk; D S Olton; P E Gold
Journal:  J Gerontol       Date:  1990-09

Review 5.  Schizotypal disorder: at the crossroads of genetics and nosology.

Authors:  M Battaglia; S Torgersen
Journal:  Acta Psychiatr Scand       Date:  1996-11       Impact factor: 6.392

Review 6.  Relationship of schizotypal personality disorder to schizophrenia: genetics.

Authors:  S Torgersen
Journal:  Schizophr Bull       Date:  1985       Impact factor: 9.306

Review 7.  The case for heterogeneity in the etiology of schizophrenia.

Authors:  M T Tsuang; S V Faraone
Journal:  Schizophr Res       Date:  1995-10       Impact factor: 4.939

Review 8.  Diagnostic accuracy and linkage analysis: how useful are schizophrenia spectrum phenotypes?

Authors:  S V Faraone; W S Kremen; M J Lyons; J R Pepple; L J Seidman; M T Tsuang
Journal:  Am J Psychiatry       Date:  1995-09       Impact factor: 18.112

Review 9.  Neuropsychological functioning among the nonpsychotic relatives of schizophrenic patients: a diagnostic efficiency analysis.

Authors:  S V Faraone; L J Seidman; W S Kremen; J R Pepple; M J Lyons; M T Tsuang
Journal:  J Abnorm Psychol       Date:  1995-05

10.  Genome-wide search for schizophrenia susceptibility loci: the NIMH Genetics Initiative and Millennium Consortium.

Authors:  C R Cloninger; C A Kaufmann; S V Faraone; D Malaspina; D M Svrakic; J Harkavy-Friedman; B K Suarez; T C Matise; D Shore; H Lee; C L Hampe; D Wynne; C Drain; P D Markel; C T Zambuto; K Schmitt; M T Tsuang
Journal:  Am J Med Genet       Date:  1998-07-10
View more
  2 in total

1.  Predicting quality of life impairment in chronic schizophrenia from cognitive variables.

Authors:  Michael S Ritsner
Journal:  Qual Life Res       Date:  2007-04-03       Impact factor: 4.147

2.  Schizophrenia Imaging Signatures and Their Associations With Cognition, Psychopathology, and Genetics in the General Population.

Authors:  Ganesh B Chand; Pankhuri Singhal; Dominic B Dwyer; Junhao Wen; Guray Erus; Jimit Doshi; Dhivya Srinivasan; Elizabeth Mamourian; Erdem Varol; Aristeidis Sotiras; Gyujoon Hwang; Paola Dazzan; Rene S Kahn; Hugo G Schnack; Marcus V Zanetti; Eva Meisenzahl; Geraldo F Busatto; Benedicto Crespo-Facorro; Christos Pantelis; Stephen J Wood; Chuanjun Zhuo; Russell T Shinohara; Haochang Shou; Yong Fan; Nikolaos Koutsouleris; Antonia N Kaczkurkin; Tyler M Moore; Anurag Verma; Monica E Calkins; Raquel E Gur; Ruben C Gur; Marylyn D Ritchie; Theodore D Satterthwaite; Daniel H Wolf; Christos Davatzikos
Journal:  Am J Psychiatry       Date:  2022-04-12       Impact factor: 19.242
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.